Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**LRP4 antisense RNA 1 (LRP4-AS1)** is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the LRP4 gene locus. It does not encode a protein but may have regulatory roles analogous to other antisense lncRNAs, typically through modulating the expression of its sense gene partner. No evidence is available as of now that LRP4-AS1 acts as a therapeutic target, has associated drugs, or is implicated as a biomarker in disease. **Notes on related confusion:** - Review of the search evidence shows most research and experimental insight is on *LRP1 antisense RNA 1 (LRP1-AS1)*, a different locus[1]. - For *LRP4* and antisense RNAs, one unrelated pathway features *RNF185-AS1* regulating LRP4 via miR-429 sponging in cancer[2] but is not about LRP4-AS1 itself. - No evidence was found in the search results for drug targeting, pathogenic roles, or biomarker utility for LRP4-AS1. If you intended another closely named molecule (such as *LRP1-AS1*), please clarify, as mechanistic and disease information could be available for that gene[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LRP4 antisense RNA 1 (non-protein coding) (LRP4-AS1).